This company has been marked as potentially delisted and may not be actively trading. Medicines (MDCO) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Blueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025 | ...April 25 at 5:43 PM | gurufocus.comBlueprint Medicines to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025April 25 at 5:43 PM | gurufocus.comBlueprint Medicines Corp (BPMC) Announces Upcoming First Quarter 2025 Financial Results ...April 25 at 5:43 PM | gurufocus.comJazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab in Treating Advanced ...April 25 at 5:42 PM | gurufocus.comHold Rating for Blueprint Medicines Amidst Near-Term Challenges and Revenue VariabilityApril 22, 2025 | tipranks.comEverest Medicines Gains Approval for Listing Rule ChangesApril 21, 2025 | tipranks.comKingworld Medicines Group Ltd. Announces 2024 AGM and Key ResolutionsApril 17, 2025 | tipranks.comBeiGene Ltd (ONC) to Announce Q1 2025 Financial Results Amidst Rebranding to BeOne Medicines | ...April 17, 2025 | gurufocus.comEXCLUSIVE: Ligand Subsidiary Pelthos Therapeutics To Combine with Channel Therapeutics Creating Pain Medicines Focused EntityApril 17, 2025 | benzinga.comEverest Medicines Announces Leadership Change and Clarifies ESOP DetailsApril 15, 2025 | tipranks.comInnovative Medicines and MedTech Strategies in 2023: Key Insights and Impacts | JNJ Stock NewsApril 15, 2025 | gurufocus.comKingworld Medicines Group Ltd. Adopts New Share Award SchemeApril 14, 2025 | tipranks.comNovartis Commits $23 Billion to U.S. Expansion, Eyes Full Domestic Production of Key MedicinesApril 11, 2025 | gurufocus.comBlueprint Medicines Continues Targeting Mast Cells For Potential Billion-Dollar GrowthApril 7, 2025 | seekingalpha.comABL Bio Announces Grabody-B Brain Delivery Platform License Agreement with GSK to Develop Novel Medicines for Neurodegenerative DiseasesApril 6, 2025 | investing.comPraxis Precision Medicines to Participate in Upcoming April ConferencesApril 3, 2025 | gurufocus.comSangamo Therapeutics Announces Capsid License Agreement With Lilly to Deliver Genomic Medicines ...April 3, 2025 | gurufocus.comPraxis Precision Medicines to Participate in Upcoming April ConferencesApril 3, 2025 | gurufocus.comRevolution Medicines Inc (RVMD) to Present at AACR Annual Meeting 2025April 1, 2025 | gurufocus.comEverest Medicines Announces New Share Option and Award GrantsApril 1, 2025 | tipranks.comRevolution Medicines (RVMD): The Best Debt Free Mid Cap Stock to Buy NowMarch 31, 2025 | insidermonkey.com3D Medicines Inc. Reports 2024 Financial Results Amid Market ChallengesMarch 31, 2025 | tipranks.com3D Medicines Inc. Forms Nomination Committee for Enhanced GovernanceMarch 31, 2025 | tipranks.com3D Medicines Announces Board Composition and Governance StructureMarch 31, 2025 | tipranks.comIs Blueprint Medicines (BPMC) One of the Best Mid Cap Biotech Stocks to Buy?March 30, 2025 | insidermonkey.comIs Revolution Medicines (RVMD) the Best Mid Cap Biotech Stock to Buy?March 30, 2025 | insidermonkey.comEuropean committee says Lilly Alzheimer’s drug shouldn’t get marketing approvalMarch 28, 2025 | financialpost.comEuropean committee says Lilly Alzheimer's drug shouldn't get marketing approvalA European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially dangerous risks of brain bleeding and swellingMarch 28, 2025 | marketbeat.comEuropean Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11March 28, 2025 | financialpost.comTYK Medicines Reports 2024 Annual Results and Corporate ChangesMarch 27, 2025 | tipranks.comFull Year 2024 Everest Medicines Ltd Earnings Call TranscriptMarch 27, 2025 | gurufocus.comEverest Medicines Ltd (FRA:6HN) (Full Year 2024) Earnings Call Highlights: Record Revenue ...March 27, 2025 | gurufocus.comUK Medicines and Healthcare Products Regulatory Agency Confirms Acceptance of Marketing Authorization Application for Proposed Biosimilar to Xolair ® (omalizumab)March 26, 2025 | investing.comEverest Medicines Announces Financial Results for Full Year Ended December 31, 2024March 25, 2025 | investing.comIs Blueprint Medicines Corporation (BPMC) a Promising Biotech Stock According to Wall Street AnalystsMarch 25, 2025 | insidermonkey.comEverest Medicines Ltd. Releases 2024 Annual ResultsMarch 25, 2025 | tipranks.comGSK’s Nucala Application for COPD Accepted by EMAMarch 24, 2025 | tipranks.comEverest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14March 23, 2025 | investing.com3D Medicines Inc. Schedules Board Meeting for Financial ReviewMarch 19, 2025 | tipranks.comDirector’s Major Stock Sale Shakes Up Blueprint Medicines!March 17, 2025 | tipranks.comGilead Sciences - Leader In HIV MedicinesMarch 14, 2025 | talkmarkets.com3D Medicines Inc. Advances ‘AI + mRNA’ Cancer Vaccine Strategy with New Patent FilingMarch 11, 2025 | tipranks.comTYK Medicines Reports Positive Phase II Trial Results for TY-9591March 9, 2025 | tipranks.comPraxis Precision Medicines Updates on Programs and FinancesMarch 5, 2025 | tipranks.comBlueprint Medicines: Hold Rating Amid Concerns Over Ayvakit’s Liver Function Test ElevationsMarch 4, 2025 | tipranks.comHHLR ADVISORS, LTD. Acquires Significant Stake in BeOne Medicines LtdMarch 4, 2025 | gurufocus.comBaker Bros. Advisors LP Reduces Stake in BeOne Medicines LtdMarch 1, 2025 | gurufocus.comPositive Outlook on Praxis Precision Medicines Amidst Phase 3 ET Program ChallengesFebruary 28, 2025 | tipranks.comPraxis Precision Medicines: Navigating Challenges and Catalysts in Epilepsy TreatmentFebruary 28, 2025 | tipranks.comEverest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine ProgramsFebruary 28, 2025 | investing.com Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address MDCO Media Mentions By Week MDCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDCO News Sentiment▼0.001.03▲Average Medical News Sentiment MDCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDCO Articles This Week▼63▲MDCO Articles Average Week Get Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for MDCO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News Today CORT News Today JAZZ News Today PRGO News Today SUPN News Today PCRX News Today OMER News Today NKTR News Today ASMB News Today CPIX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MDCO) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Medicines Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MDCO Stock Free MDCO Stock Alerts